← Leaderboards
Paul W. Spearman
Cincinnati Childrens Hosp Med Ctr
$26,612,118
Attributed
$29,661,539
Total exposure
35
Grants
23
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $2.1M · FY2005–25$2.5M$1.9M$1.3M$625K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$29,661,539 · 35
By mechanism
R01$24,406,627 · 14
R21$1,882,295 · 5
P30$1,208,412 · 1
T32$1,075,421 · 1
S10$500,000 · 1
M01$272,875 · 10
Top collaborators
- Robert Wilson Frenck4 shared
- Biao He4 shared
- Sing Sing Way4 shared
- Lou Ann S. Brown3 shared
- David Marshall Guidot3 shared
- Michael E Davis1 shared
Others in their field
Top investigators on “Cells”
- Lawrence Corey · Fred Hutchinson Cancer Center$536,344,731
- Barton F Haynes · Duke University$457,457,619
- David Heimbrook · Leidos Biomedical Research, Inc.$454,789,509
- Glenda E Gray · Wits Health Consortium (Pty), Ltd$299,104,942
- Dennis R. Burton · Scripps Research Institute$278,781,854
- Mary M Horowitz · Medical College Of Wisconsin$237,383,608
Research focus
CellsViralParticleProteinsHiv-1MediatingVirusBaseInsightLaboratoriesPathway InteractionsEventVirionCell MembraneCell TypeMacrophageSitePlayProductionTransmission ProcessTraffickingLifeResearch StudyT-Lymphocyte
Grant awards (102)
Viral and Cellular Determinants of HIV-1 Assembly$609,012
R01 · FY2025 · AI · contact PI
Modeling HIV and methamphetamine-induced neuroinflammation in cerebral organoids$598,811
R01 · FY2025 · DA · contact PI
Vaccinology Training Program$257,795
T32 · FY2025 · AI · contact PI
Viral and Cellular Determinants of HIV-1 Assembly$609,012
R01 · FY2024 · AI · contact PI
Modeling HIV and methamphetamine-induced neuroinflammation in cerebral organoids$598,813
R01 · FY2024 · DA · contact PI
Role of Siglec-1 in HIV Interactions with Microglia and Astrocytes$495,301
R01 · FY2024 · DA · contact PI
Vaccinology Training Program$335,945
T32 · FY2024 · AI · contact PI
Modeling HIV and methamphetamine-induced neuroinflammation in cerebral organoids$598,815
R01 · FY2023 · DA · contact PI
Role of Siglec-1 in HIV Interactions with Microglia and Astrocytes$495,301
R01 · FY2023 · DA · contact PI
Vaccinology Training Program$324,915
T32 · FY2023 · AI · contact PI
Modeling HIV and methamphetamine-induced neuroinflammation in cerebral organoids$598,815
R01 · FY2022 · DA · contact PI
Role of Siglec-1 in HIV Interactions with Microglia and Astrocytes$495,301
R01 · FY2022 · DA · contact PI
Viral and Cellular Determinants of HIV-1 Assembly$357,750
R01 · FY2022 · AI · contact PI
Vaccinology Training Program$156,766
T32 · FY2022 · AI · contact PI
Role of Siglec-1 in HIV Interactions with Microglia and Astrocytes$495,301
R01 · FY2021 · DA · contact PI
Role of Vpu, Tetherin, and Siglec-1 in HIV-1 Replication$408,407
R01 · FY2021 · AI · contact PI
Viral and Cellular Determinants of HIV-1 Assembly$357,750
R01 · FY2021 · AI · contact PI
Role of Siglec-1 in HIV Interactions with Microglia and Astrocytes$495,304
R01 · FY2020 · DA · contact PI
Role of Vpu, Tetherin, and Siglec-1 in HIV-1 Replication$408,407
R01 · FY2020 · AI · contact PI
Viral and Cellular Determinants of HIV-1 Assembly$357,750
R01 · FY2020 · AI · contact PI
Role of Vpu, Tetherin, and Siglec-1 in HIV-1 Replication$408,407
R01 · FY2019 · AI · contact PI
Viral and Cellular Determinants of HIV-1 Assembly$357,750
R01 · FY2019 · GM · contact PI
HIV-1 Particle Capture and VCC Formation in Microglia$198,750
R21 · FY2019 · NS · contact PI
Role of Vpu, Tetherin, and Siglec-1 in HIV-1 Replication$423,814
R01 · FY2018 · GM · contact PI
HIV-1 Particle Capture and VCC Formation in Microglia$238,500
R21 · FY2018 · NS · contact PI
Mucosal Protection Against HIV Generated by PIV5 Priming and VLP Boosting$597,176
R01 · FY2017 · AI · contact PI
Mucosal Protection Against HIV Generated by PIV5 Priming and VLP Boosting$715,150
R01 · FY2016 · AI · contact PI
Viral and Cellular Determinants of HIV-1 Assembly$310,121
R01 · FY2016 · GM · contact PI
Summer Research Experience Programs$91,775
R25 · FY2016 · HD
HIV-induced redox stress and the alveolar macrophage as a resistant reservoir$66,300
R01 · FY2016 · HL
Viral and Cellular Determinants of HIV-1 Assembly$17,794
R01 · FY2016 · GM · contact PI
HIV-induced redox stress and the alveolar macrophage as a resistant reservoir$676,959
R01 · FY2015 · HL
Mucosal Protection Against HIV Generated by PIV5 Priming and VLP Boosting$670,092
R01 · FY2015 · AI · contact PI
Role of Vpu in Retroviral Particle Assembly$387,500
R01 · FY2015 · AI · contact PI
Viral and Cellular Determinants of HIV-1 Assembly$314,359
R01 · FY2015 · GM · contact PI
Viral and Cellular Determinants of HIV-1 Assembly$66,784
R01 · FY2015 · GM · contact PI
HIV-induced redox stress and the alveolar macrophage as a resistant reservoir$687,676
R01 · FY2014 · HL
Mucosal Protection Against HIV Generated by PIV5 Priming and VLP Boosting$682,842
R01 · FY2014 · AI · contact PI
Role of Vpu in Retroviral Particle Assembly$387,500
R01 · FY2014 · AI · contact PI
Viral and Cellular Determinants of HIV-1 Assembly$314,360
R01 · FY2014 · GM · contact PI
Role of Vpu in Retroviral Particle Assembly$364,250
R01 · FY2013 · AI · contact PI
Viral and Cellular Determinants of HIV-1 Assembly$325,643
R01 · FY2013 · GM · contact PI
HIV-Specific B Cell Repertoire in Humans Following Cross-Clade Immunization$183,300
R21 · FY2013 · AI · contact PI
Role of Vpu in Retroviral Particle Assembly$387,500
R01 · FY2012 · AI · contact PI
HIV-Specific B Cell Repertoire in Humans Following Cross-Clade Immunization$248,000
R21 · FY2012 · AI · contact PI
Role of Vpu in Retroviral Particle Assembly$387,500
R01 · FY2011 · AI · contact PI
Defining Neutralization Breadth in HIV+ Human Serum$387,500
R01 · FY2010 · AI · contact PI
Viral and Cellullar Determinants of HIV-1 Assembly$324,637
R01 · FY2010 · AI · contact PI
VIROLOGY CORE$230,216
P30 · FY2010 · AI · contact PI
FEI Transmission Electron Microscope with Tomography Capability$500,000
S10 · FY2009 · RR · contact PI
Defining Neutralization Breadth in HIV+ Human Serum$387,500
R01 · FY2009 · AI · contact PI
Viral and Cellular Determinants of HIV-1 Assembly$327,916
R01 · FY2009 · AI · contact PI
VIROLOGY CORE$302,339
P30 · FY2009 · AI · contact PI
Viral and Cellular Determinants of HIV-1 Assembly$327,916
R01 · FY2008 · AI · contact PI
Role of VPU in Retroviral Particle Assembly$320,209
R01 · FY2008 · AI · contact PI
VIROLOGY CORE$260,815
P30 · FY2008 · AI · contact PI
Viral and Cellular Determinants of HIV-1 Assembly$334,267
R01 · FY2007 · AI · contact PI
Role of VPU in Retroviral Particle Assembly$326,410
R01 · FY2007 · AI · contact PI
Novel Assays for Inhibitors of HIV Assembly$253,874
R01 · FY2007 · AI · contact PI
VIROLOGY CORE$232,945
P30 · FY2007 · AI · contact PI
Pseudovirion Formation by Live Vector HIV Vaccines$222,845
R21 · FY2007 · AI · contact PI
Viral and Cellular Determinants of HIV-1 Assembly$356,000
R01 · FY2006 · AI · contact PI
Role of VPU in Retroviral Particle Assembly$336,159
R01 · FY2006 · AI · contact PI
Development of Enhanced HIV-1 Pseudovirion Vaccines$333,422
R01 · FY2006 · AI · contact PI
Novel Assays for Inhibitors of HIV Assembly$261,457
R01 · FY2006 · AI · contact PI
Pseudovirion Formation by Live Vector HIV Vaccines$229,500
R21 · FY2006 · AI · contact PI
VIROLOGY CORE$182,097
P30 · FY2006 · AI · contact PI
A PROBE STUDY OF THE SAFETY, TOLERABILITY, AND IMMUNOGENICITY OF HUMAN IMMUNO$10,006
M01 · FY2006 · RR · contact PI
NORMAL VOLUNTEER BLOOD DONATION$6,671
M01 · FY2006 · RR · contact PI
A PROBE STUDY OF THE SAFETY, TOLERABILITY AND IMMUNOGENICITY OF A THREE-DOSE$3,335
M01 · FY2006 · RR · contact PI
A PHASE I SAFETY AND IMMUNOGENICITY TRIAL OF AN ALPHAVIRUS REPLICON HIV SUBTY$1,111
M01 · FY2006 · RR · contact PI
Role of VPU in Retroviral Particle Assembly$339,750
R01 · FY2005 · AI
Novel Assays for Inhibitors of HIV Assembly$216,992
R01 · FY2005 · AI
Development of Enhanced HIV-1 Pseudovirion Vaccines$205,520
R01 · FY2005 · AI
Viral and Cellular Determinants of HIV-1 Assembly$197,647
R01 · FY2005 · AI
Development of Enhanced HIV-1 Pseudovirion Vaccines$136,008
R01 · FY2005 · AI
Viral and Cellular Determinants of HIV-1 Assembly$68,423
R01 · FY2005 · AI
Novel Assays for Inhibitors of HIV Assembly$61,691
R01 · FY2005 · AI
A PHASE I SAFETY AND IMMUNOGENICITY TRIAL OF AN ALPHAVIRUS REPLICON HIV SUBTY$42,733
M01 · FY2005 · RR
NORMAL VOLUNTEER BLOOD DONATION$30,271
M01 · FY2005 · RR
A PROBE STUDY OF THE SAFETY, TOLERABILITY, AND IMMUNOGENICITY OF HUMAN IMMUNO$19,588
M01 · FY2005 · RR
A PROBE STUDY OF THE SAFETY, TOLERABILITY AND IMMUNOGENICITY OF A THREE-DOSE$5,342
M01 · FY2005 · RR
A PHASE I DOSE-RANGING STUDY OF THE SAFETY, TOLERABILITY, AND IMMUNOGENCITY$1,779
M01 · FY2005 · RR
DEVELOPMENT OF POOLED HIV POSITIVE SERA FOR BASIC INVESTIGATIONS INTO HIV BIO$1,779
M01 · FY2005 · RR
Development of Enhanced HIV-1 Pseudovirion Vaccines$339,750
R01 · FY2004 · AI
Role of VPU in Retroviral Particle Assembly$327,000
R01 · FY2004 · AI
Viral and Cellular Determinants of HIV-1 Assembly$264,250
R01 · FY2004 · AI
Novel FRET-based Assays for HIV Assembly Inhibitors$211,200
R21 · FY2004 · AI
A PHASE I SAFETY AND IMMUNOGENICITY TRIAL OF AN ALPHAVIRUS REPLICON HIV SUBTY...$68,763
M01 · FY2004 · RR
A Probe Study of the Safety, Tolerability and Immunogenicity of a Three-Dose...$61,123
M01 · FY2004 · RR
DEVELOPMENT OF POOLED HIV POSITIVE SERA FOR BASIC INVESTIGATIONS INTO HIV BIO$11,461
M01 · FY2004 · RR
NORMAL VOLUNTEER BLOOD DONATION .$8,913
M01 · FY2004 · RR
Development of Enhanced HIV-1 Pseudovirion Vaccines$339,750
R01 · FY2003 · AI
Viral and Cellular Determinants of HIV-1 Assembly$264,250
R01 · FY2003 · AI
Novel FRET-based Assays for HIV Assembly Inhibitors$168,350
R21 · FY2003 · AI
Development of Enhanced HIV-1 Pseudovirion Vaccines$327,084
R01 · FY2002 · AI
Viral and Cellular Determinants of HIV-1 Assembly$264,469
R01 · FY2002 · AI
Viral and Cellular Determinants of HIV-1 Assembly$247,449
R01 · FY2001 · AI
MEMBRANE BINDING AND TRANSPORT OF HIV1 PR55$17,734
R29 · FY2001 · AI
DEVELOPMENT OF ENHANCED HIV 1 PSEUDOVIRION VACCINES$181,850
R21 · FY2000 · AI
MEMBRANE BINDING AND TRANSPORT OF HIV1 PR55$106,400
R29 · FY2000 · AI
INDUCTION OF KSHV REPLICATION BY HIV 1$100,000
R55 · FY2000 · CA